Cordant Inc’s Evolent Health EVH Stock Holding History

Cordant Inc’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	–	–	448
2022 Q1	$0	Buy	+8	New	+$209	﹤0.01%	1269
2021 Q4	–	Sell	-66	Closed	-$2K	–	170
2021 Q3	$2K	Buy	+66	New	+$1.58K	﹤0.01%	142

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Cordant Inc's EVH Position: Q2 2022 in Review

Cordant Inc sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 8 shares.

Cordant Inc first reported a position in EVH in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

Cordant Inc reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 8 Evolent Health shares in Q2 2022.
Cordant Inc first reported a position in Evolent Health in Q3 2021 and held it in 2 quarters.
Cordant Inc's Evolent Health position peaked at $2K in Q3 2021.
215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.